Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D005472:Fluorouracil / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010166:Palliative Care; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D014529:Uridine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011743:Pyrimidines; D005461:Fluorine; C001943:5-fluorouridine; D005472:Fluorouracil; D014529:Uridine